C1Q COMPONENT COMPLEMENT - ANVISA Registration 81357320083
Access comprehensive regulatory information for C1Q COMPONENT COMPLEMENT in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81357320083 and manufactured by THE BINDING SITE GROUP LTD. The registration is held by THE BINDING SITE BRASIL COMERCIO DE PRODUTOS PARA LABORATORIO LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, THE BINDING SITE GROUP LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81357320083
25351265188201818
23119193000108
Company Information
Dates and Status
May 21, 2018
VIGENTE
09/18/2025 19:00:01
COMPLEMENTO DE COMPONENTE C1Q
Optilite C1q Kit
THE BINDING SITE GROUP LTD
81357320146
Mar 17, 2025
COMPLEMENTO DE COMPONENTE C1Q
3diag โ C1Q - OPT Kit
TRIMERO DIAGNOSTICS, S.L.
81357320131
Jul 08, 2024
COMPLEMENTO DE COMPONENTE C1Q
Anti-C1q
ORGENTEC DIAGNOSTIKA GMBH
10300390698
May 20, 2019
COMPLEMENTO DE COMPONENTE C1Q
ANTI-C1Q
ORGENTEC DIAGNOSTIKA GMBH
10300390702
May 20, 2019
COMPLEMENTO DE COMPONENTE C1Q
Imunocomplexos circulantes (CIC-C1q) IgG
EUROIMMUN AG
81148560020
Jul 25, 2016

